Apogee Therapeutics Begins Dosing Volunteers in Phase 1 Atopic Dermatitis Trial-March 2024-www.financetom.com

Apogee Therapeutics Begins Dosing Volunteers in Phase 1 Atopic Dermatitis Trial

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Apogee Therapeutics Begins Dosing Volunteers in Phase 1 Atopic Dermatitis Trial

Aug 19, 2024 5:54 AM

08:43 AM EDT, 08/19/2024 (MT Newswires) -- Apogee Therapeutics ( APGE ) said Monday it has dosed the first participants for the phase 1 trial of APG990, the company's investigative subcutaneous treatment for atopic dermatitis.

Apogee said it expects interim data from the trial in 2025.

Shares of the company were down 2.1% in recent Monday premarket activity.

Price: 44.29, Change: -0.96, Percent Change: -2.12

Previous page： Chile's Codelco 9-month pre-tax profit at $607 mln, posts higher production Next page： Rheinmetall closing in on multi-billion-euro ammunitions contract, CEO tells Reuters

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Chile's Codelco 9-month pre-tax profit at $607 mln, posts higher production

Nov 4, 2025

SANTIAGO, Nov 4 (Reuters) - Chile's Codelco, the world's largest copper producer, on Tuesday posted a pre-tax profit of $606.9 million in the nine months to September, slightly below the $612.2 million reported in the same period last year. The state-owned miner said its own output totaled 937,000 metric tons, up 2.1% from the same period last year. The production...

Rheinmetall closing in on multi-billion-euro ammunitions contract, CEO tells Reuters

Nov 4, 2025

BERLIN (Reuters) -German defence giant Rheinmetall is in the final stages of negotiating a multi-billion-euro ammunitions supply contract, CEO Armin Papperger told Reuters in an interview on Tuesday. Speaking on the sidelines of a groundbreaking ceremony for a new ammunitions factory in Lithuania, Papperger said the deal could be worth a two-digit-billion euro figure and that Rheinmetall was also in...

LiveWire Q3 Net Loss Narrows, Revenue Rises

Nov 4, 2025

08:43 AM EST, 11/04/2025 (MT Newswires) -- LiveWire Group ( LVWR ) reported a Q3 net loss Tuesday of $0.10 per diluted share, narrowing from a loss of $0.11 a year earlier. Analysts' estimates were not readily available for comparison. Revenue for the quarter ended Sept. 30 was $5.7 million, compared with $4.4 million a year earlier. ...

Pet Valu Q3 Adjusted Earnings Down But Beat, While Revs Rise But Miss Forecast; Narrows 2025 Outlook

Nov 4, 2025

08:40 AM EST, 11/04/2025 (MT Newswires) -- Pet Valu Holdings ( PTVLF ) on Tuesday reported a slight drop in third-quarter adjusted earnings, even if it still beat analysts' estimates there, while revenues were higher but lower than forecast, all leading to the company narrowing its 2025 outlook. The company's third-quarter adjusted net income fell to C$27.6 million compared to...